| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Clinical Officer
1 company
Donald Steven Furman last filed a Form 4 in March 2022, as Chief Clinical Officer at ALHC. Donald Steven Furman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,826,538 shares of ALHC. The ALHC filings lean toward selling, a net 103,006 shares.
Donald Steven Furman has 2 Form 4 filings on record from November 2021 to March 2022, all as Chief Clinical Officer at Alignment Healthcare (ALHC), 2021–2022.
The 2 reported transactions were 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $2.0M.
The largest open-market sale was 100,000 shares of ALHC at an average $20.11 on November 23, 2021, about $2.0M. Twelve months later ALHC was down 36%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.